Breaking Research News from Breastcancer.org
Comments
-
Doctor's Recommendation Against Prophylactic Mastectomy Doesn't Seem to Affect Satisfaction With Surgery Decision
April 6, 2017
A study suggests that few women seek a second opinion when their surgeons recommend against contralateral prophylactic mastectomy and most are happy with their surgery decision. Read more...0 -
Is There a Link Between High Levels of Air Pollution and Breast Density?
April 10, 2017
A study suggests that there may be a link between breast density and living in areas with high levels of fine-particle air pollution. Read more...0 -
How Closely Are Doctors Following Breast Cancer Screening Guidelines?
April 12, 2017
Research suggests that most doctors recommend annual mammograms for all women, no matter their age. Read more...0 -
Chemo Regimen With Anthracycline Better Than Regimen Without for Early-Stage, HER2-Negative Disease With High Risk of Recurrence
April 12, 2017
An analysis of several studies found that chemotherapy regimens that include an anthracycline are better than a regimen that doesn't include an anthracycline for women diagnosed with early-stage, HER2-negative breast cancer with a high risk of recurrence. Read more...0 -
Which Surgery for Early-Stage Breast Cancer Is Most Cost-Effective?
April 13, 2017
A study suggests that mastectomy followed by reconstruction causes more complications and costs more than the other surgery options for early-stage disease. But that doesn't mean it's not a good option for some women. Read more...0 -
Unclear Explanation of Genetic Testing Results Seems to Affect Treatment Decisions
April 13, 2017
A study suggests that genetic test results are not being clearly communicated to women and may be causing them to opt for breast cancer treatment that is more aggressive than they need. Read more...0 -
Some Latina Women Feel Overloaded With Information After Breast Cancer Diagnosis
April 18, 2017
The largest study to date of how Latinas diagnosed with breast cancer rate their treatment options suggests that doctors and patients need to communicate better and work as partners to make treatment decisions. Read more...0 -
FDA Approves Marketing of Paxman Scalp Cooling System in United States
April 20, 2017
The Paxman Scalp Cooling System has received FDA clearance. Read more...0 -
Counseling, Treatment Summaries Help Doctors and Patients Better Follow Survivorship Care Plan Recommendations
April 20, 2017
A study suggests that treatment summaries and a counseling session with a survivorship care nurse can help breast cancer survivors and their doctors better follow survivorship care plans. Read more...0 -
Society of Integrative Oncology Updates Guidelines on Using Complementary Therapies During and After Breast Cancer Treatment
April 25, 2017
Meditation had the strongest evidence supporting its use, and received an A grade for reducing anxiety, treating symptoms of depression, and improving quality of life. Read more...0 -
Study Suggests Link Between Low-Dose Aspirin and Lower Risk for Specific Type of Breast Cancer
May 4, 2017
A preliminary study suggests that women who take low-dose aspirin 3 or more times per week have a lower risk of hormone-receptor-positive, HER2-negative breast cancer. Still, it's too soon to recommend women start taking low-dose aspirin to reduce breast cancer risk. Read more...0 -
More Than Half of Women Don't Get Enough Information About Reconstruction From Surgeons
May 4, 2017
A very small study suggests that more than half of women who had mastectomy made a reconstruction decision that didn't align with their goals and preferences. Read more...0 -
More Women Are Living With Metastatic Breast Cancer and Living Longer
May 18, 2017
The number of U.S. women living with metastatic breast cancer is increasing; at the same time, women with metastatic disease are living longer, especially younger women. Read more...0 -
In my own experience, that is at least in part because many cancer docs know too little about the subject. My onc, who treats many BC patients, didn't know, for example, that implant reconstruction has a high failure and complication rate in patients who have received radiation. When I gave him the stats, he was aghast. In general, the docs treated recon as a simple procedure that was no big deal. My second breast surgeon at least had the good grace to admit that he didn't know enough to advise me and offered a referral to a PS.
0 -
Report Adds More Evidence to Link Between Breast Cancer Risk and Drinking Alcohol
May 24, 2017
A report from the American Institute for Cancer Research and the World Cancer Research Fund bolsters what earlier research has strongly suggested: just one small glass of wine or other alcoholic beverage per day increases breast cancer risk; the report also strongly suggests that vigorous exercise, such as running or other high intensity cardio, decreases the risk of breast cancer. Read more...0 -
Blended Cognitive Behavioral Therapy Can Reduce Fear of Cancer Recurrence
May 24, 2017
A specific type of counseling therapy, called blended cognitive behavior therapy, can help ease the fear of a cancer recurrence in survivors. Read more...0 -
Uninsured Women More Likely to Die From Breast Cancer
May 25, 2017
Women without insurance who were diagnosed with breast cancer were 60% more likely to die from the disease. Read more...0 -
Men With BRCA Mutations Have Much Higher Risk of Cancer
May 25, 2017
One of the largest studies of its kind has found that men with BRCA mutations developed eight times as many cancers as would have been in expected in the general population. Read more...0 -
Tai Chi Helps Ease Insomnia in Breast Cancer Survivors
June 14, 2017
Tai chi eases insomnia in breast cancer survivors just as well as cognitive behavioral therapy. Read more...0 -
Xeloda Improves Survival in Women With Early-Stage, HER2-Negative Disease Who Have Residual Disease After Chemotherapy Before Surgery
June 14, 2017
A study offers more evidence that Xeloda improves both disease-free and overall survival in women diagnosed with early-stage, HER2-negative disease who have residual disease after neoadjuvant chemotherapy. Read more...0 -
where is the June 8th, New England Journal of Medicine study regarding small breast cancers
0 -
VR - please see the PM we sent you.
0 -
Lynparza Better Than Standard Chemotherapy for HER2-Negative Metastatic Breast Cancer in Women With BRCA Mutations
June 15, 2017
A study found that Lynparza improved progression-free survival by about 3 months in women diagnosed with metastatic, HER2-negative breast cancer who had a BRCA1 or BRCA2 mutation. Read more...0 -
Chemotherapy-Linked Neuropathy Can Affect Balance, Gait Even Years After Treatment Ends
June 15, 2017
Neuropathy caused by chemotherapy increases the risk of falling. Read more...0 -
Herceptin Plus Perjeta Slightly Better for High-Risk, HER2-Positive Disease Than Herceptin Alone
June 16, 2017
Adding Perjeta to Herceptin and chemotherapy after surgery to treat early-stage, HER2-positive breast cancer slightly improves survival; women diagnosed with high-risk, HER2-positive, early-stage disease got more benefits. Read more...0 -
Another Biosimilar Seems as Effective as Herceptin
June 19, 2017
Another biosimilar seems as safe and as effective as Herceptin. Read more...0 -
Experimental Abemaciclib Improves Survival in Metastatic, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
June 20, 2017
Experimental abemaciclib in combination with Faslodex offered better progression-free survival than Faslodex alone in women diagnosed with metastatic, hormone-receptor-positive, HER2-negative breast cancer. Read more...0 -
Number of Women Needing More Surgery After Lumpectomy Goes Down
June 22, 2017
Fewer women need to have more surgery after lumpectomy to remove early-stage breast cancer. Read more...0 -
Number of Women Needing More Surgery After Lumpectomy Goes Down
June 22, 2017
Fewer women need to have more surgery after lumpectomy to remove early-stage breast cancer. Read more...0 -
New American College of Obstetricians and Gynecologists Guidelines Recommend Women Be Offered Mammograms at Age 40
June 23, 2017
New ACOG guidelines recommend average-risk women be offered annual screening mammograms at age 40; the decision about when to start screening should be made by each woman after discussion with her doctor. Read more...0
